EU Draft Guidelines On Biosimilar Antibodies Go Easy On Generics Firms, But Originators Need Not Panic
Executive Summary
Following the publication of its biosimilar monoclonal antibodies guidelines on Nov. 26, the European Medicines Agency has paved the way for generics manufacturers to make further inroads into this $36 billion global market.